Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Exclusion Criteria

• •The use of steroidal oral contraceptives, or any drug that could alter oral contraception metabolism will be prohibited during the study.
• •Women with a history of endometrial ablation or dilatation and curettage within 2 months prior to study start will be excluded.